Cohance Lifesciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cohance Lifesciences has submitted a routine compliance certificate to BSE and NSE for the quarter ended December 31, 2025. The certificate was issued by KFin Technologies, the company's Registrar and Share Transfer Agent, and confirms that details of shares dematerialised and rematerialised during the quarter have been furnished to all stock exchanges where the company is listed. Separate confirmations were filed with both NSDL and CDSL, the two depositories in India. This is a standard quarterly regulatory filing required under SEBI's depository regulations.
This is a routine compliance disclosure with no material impact on shareholders or the stock price. It simply confirms that share transfer and demat activity records have been properly reported to the stock exchanges.